Federal healthcare officials told drug manufacturer UCB yesterday its restrictions on 340B pricing when covered entities use contract pharmacies are illegal and must stop or the company could face civil monetary penalties of up to $6,323.00 for each
…Blog Posts
A federal district judge was right to decide that drug manufacturer Lilly cannot tie strings to 340B pricing on its drugs, the U.S. Justice Department told a federal appeals court in Chicago on Friday.
…SPONSORED CONTENT
The 340B drug pricing program enables covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services. But 340B’s benefit goes beyond providing office visits with a physician and prescriptions to control HIV. 340B also supports the execution of many pharmacy support services. One is AIDS Healthcare Foundation’s Strategic Response Team (SRT).
Alsean Bryant, an AHF pharmacist
…One of two groups of Florida health care providers that drug maker Gilead accused of making fraudulent 340B-related transactions involving the company’s HIV pre-exposure prophylaxis drugs agreed last week to settle Gilead’s claims against it for $33 million.
…A U.S. Supreme Court decision last week about the Medicare disproportionate share adjustment percentage calculation will have little effect on hospitals currently in the 340B drug pricing program, experts say.
…A new bipartisan bill to make insulin more affordable for patients could be up for a U.S. Senate vote as early as next month.
The U.S. Supreme Court’s unanimous June 15 ruling that huge cuts in 340B hospitals’ Medicare Part B drug reimbursement were unlawful “is a clear and much welcome victory for 340B hospitals,” 340B Report Publisher and CEO Ted Slafsky
…How to Handle Increased Manufacturer Inquiries…From Manufacturers With Extraordinary Price Increases
SPONSORED CONTENT
So you’ve received a “good faith” inquiry from a manufacturer questioning your purchases and utilization. You have run the numbers and don’t see anything that indicates an issue. It may seem like it’s out of the blue because these products may have low overall spend or low volume and may not hit your internal markers for audit flags. 340B
…The White House now says that this is the target month for releasing a long delayed proposed rule to replace 340B program dispute resolution regulations.
…U.S. Sens. Rick Scott (R-Fla.) and Ben Ray Luján (D-N.M.) have introduced a bill to let Ryan White clinics use income from being in the HIV/AIDS program to provide pre-exposure prophylaxis, or PrEP, a daily medication used to
…*Sign up for news summaries and alerts from 340B Report